Showing results (421-430 of 623) with videos related to
Sort By:
Pageof 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Improving cancer outcomes through international collaboration in academic cancer treatment trialsEdward L Trimble, Jeffrey S Abrams, Ralph M Meyer, et al.Journal of the American Chemical Society|May 7, 2016
A Versatile and Scalable Strategy to Discrete OligomersJimmy Lawrence, Sang-Ho Lee, Allison Abdilla, et al.American Heart Journal|April 1, 2009
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registryEric M Crespo, Gustavo B F Oliveira, Emily F Honeycutt, et al.The New England Journal of Medicine|October 11, 2003
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancerPaul E Goss, James N Ingle, Silvana Martino, et al.The Journal of Clinical Investigation|March 10, 2026
Graft-derived VWF drives platelet activation and thrombocytopenia during porcine liver xenotransplantation to brain-dead human recipientsLiang Zhao, Sokratis A Apostolidis, Aae Suzuki, et al.The Journal of Clinical Investigation|January 31, 2023
Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm modelsXu Han, Yang Mei, Rama K Mishra, et al.Journal of the National Cancer Institute|September 8, 2005
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17Paul E Goss, James N Ingle, Silvana Martino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifenPaul E Goss, James N Ingle, Joseph L Pater, et al.Breast Cancer Research and Treatment|March 17, 2006
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trialJames N Ingle, Dongsheng Tu, Joseph L Pater, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17Paul E Goss, James N Ingle, Silvana Martino, et al.Pageof 63